STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Tarsus to Participate in Upcoming Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Tarsus (NASDAQ:TARS) management will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston on Tuesday, November 11, 2025 at 11:30 a.m. PT / 2:30 p.m. ET. A live webcast will be available and replays will be posted on the company's events page within 48 hours and archived for a limited time.

Tarsus (NASDAQ:TARS) parteciperà a una chiacchierata informale al Guggenheim 2nd Annual Healthcare Innovation Conference a Boston il martedì 11 novembre 2025 alle 11:30 a.m. PT / 2:30 p.m. ET. Una diretta webcast sarà disponibile e i replay saranno pubblicati sulla pagina degli eventi dell'azienda entro 48 ore e archiviati per un periodo limitato.

Tarsus (NASDAQ:TARS) participará en una charla informal durante la Guggenheim 2nd Annual Healthcare Innovation Conference en Boston el martes 11 de noviembre de 2025 a las 11:30 a.m. PT / 2:30 p.m. ET. Se transmitirá en vivo y las repeticiones se publicarán en la página de eventos de la empresa dentro de 48 horas y se conservarán por un tiempo limitado.

Tarsus (NASDAQ:TARS) 경영진은 보스턴에서 열리는 Guggenheim 2nd Annual Healthcare Innovation Conference의 파이어사이드 채팅에 참여할 예정이며, 2025년 11월 11일 화요일 오전 11:30 PT / 오후 2:30 ET에 진행됩니다. 라이브 웹캐스트가 제공되며 재방송은 회사의 이벤트 페이지에 48시간 이내 게시되며 제한된 기간 동안 보관됩니다.

Tarsus (NASDAQ:TARS) participera à une causerie informelle lors du Guggenheim 2nd Annual Healthcare Innovation Conference à Boston le Mardi 11 novembre 2025 à 11:30 a.m. PT / 2:30 p.m. ET. Une retransmission en direct sera disponible et les replays seront publiés sur la page des événements de l'entreprise dans 48 heures et archivés pendant une durée limitée.

Tarsus (NASDAQ:TARS) wird an einem Fireside-Chat beim Guggenheim 2nd Annual Healthcare Innovation Conference in Boston teilnehmen am Dienstag, 11. November 2025 um 11:30 a.m. PT / 2:30 p.m. ET. Ein Live-Stream wird verfügbar sein und Wiederholungen werden innerhalb von 48 Stunden auf der Veranstaltungsseite des Unternehmens veröffentlicht und für eine begrenzte Zeit archiviert.

Tarsus (NASDAQ:TARS) ستشارك الإدارة في دردشة Fireside خلال مؤتمر Guggenheim السنوي الثاني للابتكار في الرعاية الصحية في بوسطن يوم الثلاثاء 11 نوفمبر 2025 في 11:30 صباحاً بتوقيت المحيط الهادئ / 2:30 ظهراً بتوقيت شرق الولايات المتحدة. سيكون هناك بث مباشر وسيتم نشر الإعادات على صفحة فعاليات الشركة خلال 48 ساعة وسيتم أرشفتها لمدة محدودة.

Positive
  • None.
Negative
  • None.

IRVINE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, MA on Tuesday, November 11th, at 11:30 a.m. PT / 2:30 p.m. ET.

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, all of which are in Phase 2.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com


FAQ

When will Tarsus (TARS) present at the Guggenheim Healthcare Innovation Conference?

Tarsus management will present on Tuesday, November 11, 2025 at 11:30 a.m. PT / 2:30 p.m. ET.

How can investors watch the Tarsus (TARS) fireside chat on November 11, 2025?

A live webcast will be available and can be accessed via the events section on the Tarsus website.

Will a replay of the Tarsus (TARS) Guggenheim presentation be available?

Yes. Replays will be posted on the Tarsus website within 48 hours and archived for a limited time.

Where on the Tarsus website can I find the webcast and replay for the November 11, 2025 event?

The webcast and replay will be available in the events section of the Tarsus investor website.

What time is the Tarsus (TARS) presentation in Eastern Time on November 11, 2025?

The fireside chat is scheduled for 2:30 p.m. ET on November 11, 2025.

How long will the replay of the Tarsus (TARS) Guggenheim presentation be archived?

The replay will be archived on the Tarsus website for a limited time; no specific duration was provided.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.89B
39.24M
3.18%
118.17%
16.41%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE